Touchstone International Medical Science Co Ltd Capital Reinvestment Ratio
Touchstone International Medical Science Co Ltd capital reinvestment ratio. Touchstone International Medical Science Co Ltd (688013) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥27.05 Million) in capital expenditures (CN¥8.28 Million). Check how aggressively does Touchstone International Medical Science reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Touchstone International Medical Science Co Ltd (2017–2024)
Capital reinvestment ratio of Touchstone International Medical Science Co Ltd from 2017 to 2024. This chart tracks Touchstone International Medical Science Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore Touchstone International Medical Science (688013) equity growth momentum to track the company's year-over-year net asset growth rate.
Touchstone International Medical Science Co Ltd Capital Reinvestment Ratio by Year (2017–2024)
Touchstone International Medical Science Co Ltd capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see Touchstone International Medical Science (688013) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | CN¥53.41 Million | CN¥41.94 Million | ▲ +253.8% |
| 2023 | 0.22x | CN¥82.95 Million | CN¥18.41 Million | ▼ -76.5% |
| 2022 | 0.95x | CN¥50.40 Million | CN¥47.67 Million | ▲ +526.2% |
| 2021 | 0.15x | CN¥60.98 Million | CN¥9.21 Million | ▼ -12.9% |
| 2020 | 0.17x | CN¥42.08 Million | CN¥7.29 Million | ▼ -35.9% |
| 2019 | 0.27x | CN¥34.82 Million | CN¥9.41 Million | ▼ -55.2% |
| 2018 | 0.60x | CN¥34.44 Million | CN¥20.78 Million | ▼ -68.7% |
| 2017 | 1.93x | CN¥7.88 Million | CN¥15.21 Million | — |